208 related articles for article (PubMed ID: 31129097)
1. Sub-region based radiomics analysis for survival prediction in oesophageal tumours treated by definitive concurrent chemoradiotherapy.
Xie C; Yang P; Zhang X; Xu L; Wang X; Li X; Zhang L; Xie R; Yang L; Jing Z; Zhang H; Ding L; Kuang Y; Niu T; Wu S
EBioMedicine; 2019 Jun; 44():289-297. PubMed ID: 31129097
[TBL] [Abstract][Full Text] [Related]
2. A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer.
Luo HS; Huang SF; Xu HY; Li XY; Wu SX; Wu DH
Radiat Oncol; 2020 Oct; 15(1):249. PubMed ID: 33121507
[TBL] [Abstract][Full Text] [Related]
3. Pre-treatment CT radiomics to predict 3-year overall survival following chemoradiotherapy of esophageal cancer.
Larue RTHM; Klaassen R; Jochems A; Leijenaar RTH; Hulshof MCCM; van Berge Henegouwen MI; Schreurs WMJ; Sosef MN; van Elmpt W; van Laarhoven HWM; Lambin P
Acta Oncol; 2018 Nov; 57(11):1475-1481. PubMed ID: 30067421
[TBL] [Abstract][Full Text] [Related]
4. Application of contrast-enhanced CT radiomics in prediction of early recurrence of locally advanced oesophageal squamous cell carcinoma after trimodal therapy.
Tang S; Ou J; Liu J; Wu YP; Wu CQ; Chen TW; Zhang XM; Li R; Tang MJ; Yang LQ; Tan BG; Lu FL; Hu J
Cancer Imaging; 2021 May; 21(1):38. PubMed ID: 34039403
[TBL] [Abstract][Full Text] [Related]
5. Imaging biomarkers of contrast-enhanced computed tomography predict survival in oesophageal cancer after definitive concurrent chemoradiotherapy.
Zeng C; Zhai T; Chen J; Guo L; Huang B; Guo H; Liu G; Zhuang T; Liu W; Luo T; Wu Y; Peng G; Li D; Chen C
Radiat Oncol; 2021 Jan; 16(1):8. PubMed ID: 33436018
[TBL] [Abstract][Full Text] [Related]
6. Prediction of Locoregional Recurrence-Free Survival of Oesophageal Squamous Cell Carcinoma After Chemoradiotherapy Based on an Enhanced CT-Based Radiomics Model.
Kong J; Zhu S; Shi G; Liu Z; Zhang J; Ren J
Front Oncol; 2021; 11():739933. PubMed ID: 34631575
[TBL] [Abstract][Full Text] [Related]
7. CT radiomics features of meso-esophageal fat in predicting overall survival of patients with locally advanced esophageal squamous cell carcinoma treated by definitive chemoradiotherapy.
Yan S; Li FP; Jian L; Zhu HT; Zhao B; Li XT; Shi YJ; Sun YS
BMC Cancer; 2023 May; 23(1):477. PubMed ID: 37231388
[TBL] [Abstract][Full Text] [Related]
8. External validation of a prognostic model incorporating quantitative PET image features in oesophageal cancer.
Foley KG; Shi Z; Whybra P; Kalendralis P; Larue R; Berbee M; Sosef MN; Parkinson C; Staffurth J; Crosby TDL; Roberts SA; Dekker A; Wee L; Spezi E
Radiother Oncol; 2019 Apr; 133():205-212. PubMed ID: 30424894
[TBL] [Abstract][Full Text] [Related]
9. Prediction of response after chemoradiation for esophageal cancer using a combination of dosimetry and CT radiomics.
Jin X; Zheng X; Chen D; Jin J; Zhu G; Deng X; Han C; Gong C; Zhou Y; Liu C; Xie C
Eur Radiol; 2019 Nov; 29(11):6080-6088. PubMed ID: 31028447
[TBL] [Abstract][Full Text] [Related]
10. Machine learning models predict overall survival and progression free survival of non-surgical esophageal cancer patients with chemoradiotherapy based on CT image radiomics signatures.
Cui Y; Li Z; Xiang M; Han D; Yin Y; Ma C
Radiat Oncol; 2022 Dec; 17(1):212. PubMed ID: 36575480
[TBL] [Abstract][Full Text] [Related]
11. Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy and its added value to Human Papillomavirus status.
Ou D; Blanchard P; Rosellini S; Levy A; Nguyen F; Leijenaar RTH; Garberis I; Gorphe P; Bidault F; Ferté C; Robert C; Casiraghi O; Scoazec JY; Lambin P; Temam S; Deutsch E; Tao Y
Oral Oncol; 2017 Aug; 71():150-155. PubMed ID: 28688683
[TBL] [Abstract][Full Text] [Related]
12. Contrast-enhanced CT radiomics features to predict recurrence of locally advanced oesophageal squamous cell cancer within 2 years after trimodal therapy: A case-control study.
Tang S; Ou J; Wu YP; Li R; Chen TW; Zhang XM
Medicine (Baltimore); 2021 Jul; 100(27):e26557. PubMed ID: 34232198
[TBL] [Abstract][Full Text] [Related]
13. Predicting response to CCRT for esophageal squamous carcinoma by a radiomics-clinical SHAP model.
Cheng X; Zhang Y; Zhu M; Sun R; Liu L; Li X
BMC Med Imaging; 2023 Oct; 23(1):145. PubMed ID: 37779188
[TBL] [Abstract][Full Text] [Related]
14. A novel CT-based radiomics model for predicting response and prognosis of chemoradiotherapy in esophageal squamous cell carcinoma.
Kasai A; Miyoshi J; Sato Y; Okamoto K; Miyamoto H; Kawanaka T; Tonoiso C; Harada M; Goto M; Yoshida T; Haga A; Takayama T
Sci Rep; 2024 Jan; 14(1):2039. PubMed ID: 38263395
[TBL] [Abstract][Full Text] [Related]
15. Development and Validation of a MRI-Based Radiomics Prognostic Classifier in Patients with Primary Glioblastoma Multiforme.
Chen X; Fang M; Dong D; Liu L; Xu X; Wei X; Jiang X; Qin L; Liu Z
Acad Radiol; 2019 Oct; 26(10):1292-1300. PubMed ID: 30660472
[TBL] [Abstract][Full Text] [Related]
16. Radiomics and dosiomics for predicting complete response to definitive chemoradiotherapy patients with oesophageal squamous cell cancer using the hybrid institution model.
Kawahara D; Murakami Y; Awane S; Emoto Y; Iwashita K; Kubota H; Sasaki R; Nagata Y
Eur Radiol; 2024 Feb; 34(2):1200-1209. PubMed ID: 37589902
[TBL] [Abstract][Full Text] [Related]
17. Predicting the need for a replan in oropharyngeal cancer: A radiomic, clinical, and dosimetric model.
Chinnery TA; Lang P; Nichols AC; Mattonen SA
Med Phys; 2024 May; 51(5):3510-3520. PubMed ID: 38100260
[TBL] [Abstract][Full Text] [Related]
18. A prediction model for degree of differentiation for resectable locally advanced esophageal squamous cell carcinoma based on CT images using radiomics and machine-learning.
Kawahara D; Murakami Y; Tani S; Nagata Y
Br J Radiol; 2021 Aug; 94(1124):20210525. PubMed ID: 34235955
[TBL] [Abstract][Full Text] [Related]
19. Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Cui Y; Yang X; Shi Z; Yang Z; Du X; Zhao Z; Cheng X
Eur Radiol; 2019 Mar; 29(3):1211-1220. PubMed ID: 30128616
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Intratumoral and Peritumoral Computed Tomography Radiomics for Predicting Pathological Complete Response to Neoadjuvant Chemoradiation in Patients With Esophageal Squamous Cell Carcinoma.
Hu Y; Xie C; Yang H; Ho JWK; Wen J; Han L; Chiu KWH; Fu J; Vardhanabhuti V
JAMA Netw Open; 2020 Sep; 3(9):e2015927. PubMed ID: 32910196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
